Idarucizumab more effectively reverses the anticoagulant effects of dabigatran acylglucuronide than dabigatran by Jong-Min Kim, Young Yoon Bang, Kyoung-Ah Kim, Jin-Woo Park, Ji-Young Park

Subjects: “…Dabigatran…”
Get full text

The CES1 Gene rs2244613 Minor Allele Impact on the Safety Profile of Dabigatran Etexilate: Meta-Analysis by S. P. Abdullaev, K. B. Mirzaev, P. O. Bochkov, I. N. Sychev, D. A. Sychev

Subjects: Get full text

UGT2B15 single nucleotide polymorphism reduces dabigatran acylglucuronide formation in humans by Jin-Woo Park, Jin-Woo Park, Jin-Woo Park, Jong-Min Kim, Young Yoon Bang, Kyoung-Ah Kim, Sungwook Yu, Ji-Young Park

Subjects: “…dabigatran…”
Get full text

IDARUCIZUMAB, A SPECIFIC REVERSAL AGENT FOR DABIGATRAN: THE PRESENT-DAY KNOWLEDGE by Olga O. Shakhmatova

Subjects: Get full text

Dabigatran etexilate for nonvalvular atrial fibrillation in real practice and promises for its use to prevent stroke by A.V. Fonyakin

Subjects: Get full text

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS by M. Yu. Gilyarov, V. A. Sulimov

Subjects: Get full text

Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology by S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova

Subjects: Get full text

Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology by Sergey N. Bel'diev, Irina V. Medvedeva, Dmitry Yu. Platonov, Galina Yu. Trufanova

Subjects: Get full text

Pharmacokinetics and Pharmacogenetics of Dabigatran by A. V. Savinova, V. S. Dobrodeeva, M. M. Petrova, R. F. Nasyrova, N. A. Shnayder

Subjects: Get full text

DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER by I. S. Yavelov

Subjects: Get full text

HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION by S. V. Moiseev

Subjects: Get full text

Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells by Sergey Nikolaevich Bel'diev, Irina Vladimirovna Medvedeva, Dmitry Jur'evich Platonov

Subjects: “…dabigatran, apixaban, rivaroxaban, edoxaban, drug interactions…”
Get full text

Hemorrhage risk associated with triple antithrombotic therapy: a focused real-world pharmacovigilance disproportional analysis study by Kannan Sridharan, Gowri Sivaramakrishnan

Subjects: Get full text

Dabigatran etexilate in patients with nonvalvular atrial fibrillation: benefits of application in certain clinical situations by E. I. Baranova, Zhanna Kobalava

Subjects: Get full text

Risk Factors of Gastrointestinal Bleeding in Patients Receiving New Oral Anticoagulants by Ju Yup Lee

Subjects: Get full text

DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS by S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov

Subjects: “…dabigatran…”
Get full text

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation by N. A. Novikova, A. N. Volovchenko

Subjects: Get full text

Pharmacokinetics and bioequivalence of the generic and original dabigatran etexilate after a single dose in healthy volunteers by V. B. Vasilyuk, M. V. Faraponova, A. B. Verveda, G. I. Syraeva, Yu. B. Vikharev, A. V. Popov, A. L. Kovalenko

Subjects: “…dabigatran etexilate…”
Get full text

Diastolic blood pressure achieved at target systolic blood pressure (120–140 mm Hg) and dabigatran-related bleeding in patients with nonvalvular atrial fibrillation: A real-world s... by Yu Yu, Minghui Li, Wei Zhou, Tao Wang, Lingjuan Zhu, Lihua Hu, Huihui Bao, Xiaoshu Cheng

Subjects: Get full text

Cost-effectiveness of dabigatran for thromboembolic events prevention in atrial fibrillation patients in Chile by Tomás Abbot, Nicolás Armijo, Luis Rojas Orellana, Andrés Giglio Jiménez, Carlos Balmaceda, Manuel Espinoza

Subjects: Get full text